BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sellens E, Bosward KL, Norris JM, Wood N, Heller J, Graves S, Gidding HF. Coxiella burnetii seroprevalence in unvaccinated veterinary workers in Australia: Evidence to support Q fever vaccination. Zoonoses Public Health 2020;67:79-88. [PMID: 31677254 DOI: 10.1111/zph.12658] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fratzke AP, van Schaik EJ, Samuel JE. Immunogenicity and Reactogenicity in Q Fever Vaccine Development. Front Immunol 2022;13:886810. [DOI: 10.3389/fimmu.2022.886810] [Reference Citation Analysis]
2 Stufano A, Iatta R, Sgroi G, Jahantigh HR, Cagnazzo F, Flöel A, Lucchese G, Loconsole D, Centrone F, Mendoza-Roldan JA, Chironna M, Otranto D, Lovreglio P. Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors. Parasit Vectors 2022;15:264. [PMID: 35879782 DOI: 10.1186/s13071-022-05385-6] [Reference Citation Analysis]
3 Long CM, Beare PA, Cockrell DC, Fintzi J, Tesfamariam M, Shaia CI, Heinzen RA. Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity. NPJ Vaccines 2021;6:38. [PMID: 33741986 DOI: 10.1038/s41541-021-00296-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tellis AN, Rowe SM, Coilparampil R, Jenkins C, Dart A, Zadoks RN, Regnerus CD, Bosward KL. Evaluation of three immunological assays to mitigate the risk of transboundary spread of Coxiella burnetii by alpacas. Transbound Emerg Dis 2021. [PMID: 33655708 DOI: 10.1111/tbed.14051] [Reference Citation Analysis]
5 Mathews KO, Toribio JA, Norris JM, Phalen D, Wood N, Graves SR, Sheehy PA, Bosward KL. Coxiella burnetii seroprevalence and Q fever in Australian wildlife rehabilitators. One Health 2021;12:100197. [PMID: 33319024 DOI: 10.1016/j.onehlt.2020.100197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Fratzke AP, Jan S, Felgner J, Liang L, Nakajima R, Jasinskas A, Manna S, Nihesh FN, Maiti S, Albin TJ, Esser-Kahn AP, Davies DH, Samuel JE, Felgner PL, Gregory AE. Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against Coxiella burnetii While Minimizing Reactogenic Responses. Front Immunol 2021;12:653092. [PMID: 33815413 DOI: 10.3389/fimmu.2021.653092] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Sahu R, Rawool DB, Vinod VK, Malik SVS, Barbuddhe SB. Current approaches for the detection of Coxiella burnetii infection in humans and animals. J Microbiol Methods 2020;179:106087. [PMID: 33086105 DOI: 10.1016/j.mimet.2020.106087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mathews KO, Phalen D, Norris JM, Stenos J, Toribio JA, Wood N, Graves S, Sheehy PA, Nguyen C, Bosward KL. Serological Evidence of Exposure to Spotted Fever Group and Typhus Group Rickettsiae in Australian Wildlife Rehabilitators. Pathogens 2021;10:745. [PMID: 34204809 DOI: 10.3390/pathogens10060745] [Reference Citation Analysis]
9 Siengsanan-lamont J, Blacksell SD. Surveillance for One Health and high consequence veterinary pathogens (Brucellosis, Coxiellosis and Foot and Mouth Disease) in Southeast Asia: Lao PDR and Cambodia in focus and the importance of international partnerships. Microbiol Aust 2021;42:156. [DOI: 10.1071/ma21045] [Reference Citation Analysis]